Chronic Disease Management

 

HBI 2020: Medtech and services – new partnerships and opportunities

The relationship between medtech and its customers is changing. No longer is medtech wheeled out for a one-off purchase. Long-term partnerships are being built, and patients and providers are benefitting. An expert panel at HBI 2020 explored the burgeoning relationship between medtech and services, and some of the challenges this presented.

Interview: Klaus Boehncke, Partner, L.E.K. Consulting 

What can you do with AI and big data today and what will be possible within three years? Why has adoption been slower than you might have expected? And what sort of role should health care providers look to play? HBI gets an expert view from digital, technology and business strategy expert Klaus Boehncke, partner at L.E.K. Consulting, who is chairing the Best Practice Workshop: Delivering Digital Excellence: A Framework for Success at HBI 2020 in two weeks.

Bringing costs down in South East Asia

HBI State of the Regions continued on Tuesday morning with a look at SE Asia. It's "overloaded" in some parts with "substantial coverage gaps" in others, with big provider/payor conflict in most. Eduardo Banzon from the Asian Development Bank, Cole Sirucek from DocDoc, and Angus Slater from Bupa talk about the biggest challenges and opportunities on the continent.

Interview: Jan Leister, executive director of digital health, Fresenius Helios

Fresenius Helios has a new incoming digital health executive, who after heading up the Fresenius Group's German rehab business for the past four years wants to disrupt the way it manages chronic disease by transforming it from a pure hospital operator into a digi-physical healthcare group. Leister tells HBI that he wants to sell its digital therapeutics solution Curalie right into emerging markets.

Kaia Health eyeing France and UK launch

German digital therapeutics (DTx) app Kaia Health tells HBI it will soon launch in France and the UK after completing Europe's largest randomised control trial (RCT) for DTx focused on a chronic disease. 

DocDoc expands into China

Singapore-based 'doctor discovery platform' DocDoc has moved into China through a partnership with one of the world's largest insurance risk management companies, Kaitaiming (KTM), giving it access to 90% of the country's insurers. HBI speaks to CEO Cole Sirucek.

COVID-19: Care sector confronts crisis, hospitals hit hard

In the second of our two-part deep dive into how COVID-19 is hitting healthcare markets across EMEA, we ask how hospitals are coping with spiralling staff sickness and a flood of patients, and whether the care and dialysis sectors can stay afloat given the risk the virus poses to their most vulnerable patients.

Find Us